A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.

Chaoyang SunEnsong GuoBo ZhouWanying ShanJia HuangDanhui WengPeng WuChangyu WangShixuan WangWei ZhangQinglei GaoXiaoyan XuBeibei WangJunbo HuDing MaGang Chen

Published in: BMC cancer (2019)

ROS status is associated with chemotherapy resistance. ROS score system might be a prognostic biomarker in predicting the survival benefit from ovarian cancer patients.

Keyphrases

reactive oxygen species
end stage renal disease
ejection fraction
newly diagnosed
cell death
prognostic factors
dna damage
squamous cell carcinoma
oxidative stress
free survival